Antiviral action of interferon-α against hepatitis C virus replicon and its modulation by interferon-γ and interleukin-8

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 8, 2007, Pages 1278-1285

  Jia, Yintang ^a   Wei, Lai ^a   Jiang, Dong ^a   Wang, Jianghua ^a   Cong, Xu ^a   Fei, Ran ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Hepatitis C virus replicon; Interferon ; Interferon ; Interleukin 8

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 8;

ANTIVIRAL ACTIVITY; ARTICLE; ATTENUATION; COMPREHENSION; CULTURE MEDIUM; DOWN REGULATION; DRUG INHIBITION; DRUG MECHANISM; GENE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MODULATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; THERAPY EFFECT; VIRUS INFECTION; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 34547692459     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.04957.x     Document Type: Article

References (35)

1. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin. Liver Dis. 2000 20 : 1 16.
2. Alter HJ, Seef LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin. Liver Dis. 2000 20 : 17 35.
3. McHutchison JG, Gordon SC, Schiff ER et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N. Engl. J. Med. 1998 339 : 1485 92.
4. Fried MW, Schiffman ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 2002 347 : 975 82.
5. Poynard T, Marcellin P, Lee SS et al. Randomized trial of interferon a2b plus ribavirin for 48 weeks or for 24 weeks versus interferon a2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998 35 : 1426 32.
6. Gerlach JT, Diepolder HM, Jung MC et al. Recurrence of hepatitis C virus after loss of virus-specific CD4+T-cell response in acute hepatitis C. Gastroenterology 1999 117 : 933 41.
7. Guidotti LG, Rochford R, Chung J et al. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999 284 : 825 9.
8. Lanford RE, Guerra B, Lee H et al. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly (i) -poly (c), tumor necrosis factor alpha, and ribavirin in hepatitis c virus subgenomic replicons. J. Virol. 2003 77 : 1092 104.
9. Der SD, Zhou A, Williams BR et al. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 1998 95 : 15623 8.
10. Stark GR, Kerr IM, Williams BRG et al. How cells respond to interferons. Annu. Rev. Biochem. 1998 67 : 227 64.
11. Goodbourn S, Didcock L, Randall RE. Interferons: cell signaling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 2000 81 : 2341 64.
12. Tan S, Katze MG. How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology 2001 284 : 1 12.
13. Gale MJ Jr., Korth MJ, Tang NM et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997 230 : 217 27.
14. Polyak SJ, Paschal D, McArdle S et al. Characterization of the effects of hepatitis C virus non-structural 5A protein expression in human cell lines and on interferon-sensitive virus replication. Hepatology 1999 29 : 1262 71.
15. Girard S, Shalhoub P, Lescure P et al. An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 2002 295 : 272 83.
16. Khabar KSA, Al-Zoghaibi F, Al-Ahdal MN et al. The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha. J. Exp. Med. 1997 186 : 1077 85.
17. Khabar KSA, Murayama T, al-Ahdal MN et al. Interleukin-8 is induced by viruses, enhances cytomegalovirus and picornavirus replication, and inhibits the antiviral action of inteferon-alpha. In: Jameel S, Villaneal L. Advances in Animal Virology. Enfield, NH : Science Publishers, 2000.
18. Bartenschlager R, Kaul A, Sparacio S. Replication of the hepatitis C virus in cell culture. Antivir. Res. 2003 60 : 91 102.
19. Huibi C, Anan W, Bernard M et al. Down-regulation of IL-8 expression in human airway epithelial cells through helper-dependent adenoviral-mediated RNA interference. Cell Res. 2005 15 : 111 19.
20. Krieger N, Lohmann V, Bartenschlager R. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J. Virol. 2001 75 : 4614 24.
21. Lohmann V, Korner F, Dobierzewska A, Bartenschlager R. Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J. Virol. 2001 75 : 1437 49.
22. Levy DE, Lew DJ, Decker T et al. Synergistic interaction between interferon-alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J. 1990 9 : 1105 11.
23. Polyak SJ, Khabar KS, Rezeiq M, Gretch DR et al. Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J. Virol. 2001 75 : 6209 11.
24. Mihm U, Herrmann E, Sarrazin U et al. Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C. J. Hepatol. 2004 40 : 845 52.
25. Samuel CE. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001 14 : 778 809.
26. Zhu H, Zhao H, Collins CD et al. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 2003 37 : 1180 88.
27. Espert L, Degols G, Gongora C et al. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J. Biol. Chem. 2003 278 : 16151 8.
28. Frese M, Pietschmann T, Moradpour D et al. Interferon-α inhibits hepatitis C virus subgenomic RNA replication by MxA-independent pathway. J. Gen. Virol. 2001 82 : 723 33.
29. Guo JT, Bichko VV, Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J. Virol. 2001 75 : 8516 23.
30. Namba K, Naka K, Dansako H et al. Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype. Biochem. Biophys. Res. Commun 2004 323 : 299 309.
31. Cheney IW, Lai VCH, Zhong W et al. Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J. Virol. 2002 76 : 11148 54.
32. Song J, Fujii M, Wang F et al. The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon. J. General Virol. 1999 80 : 879 86.
33. Francois C, Duverlie G, Rebouillat D et al. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J. Virol. 2000 74 : 5587 96.
34. Polyak SJ, Khabar KS, Paschal DM et al. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J. Virol. 2001 75 : 6095 106.
35. Geiss GK, Carter VS, He Y. Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J. Virol. 2003 77 : 6367 75.